Impact of currently prescribed lipid-lowering drugs on plasma PCSK9 concentration: single or in combination study in rats.
about
Traditional Chinese medicine for lipid metabolism disorders.Impacts of ezetimibe on PCSK9 in rats: study on the expression in different organs and the potential mechanisms.Relationship Between Low-Density Lipoprotein Cholesterol, Free Proprotein Convertase Subtilisin/Kexin Type 9, and Alirocumab Levels After Different Lipid-Lowering StrategiesEfficacy and safety of Zhibitai in combination with atorvastatin for lipid lowering in patients with coronary heart disease.
P2860
Impact of currently prescribed lipid-lowering drugs on plasma PCSK9 concentration: single or in combination study in rats.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of currently prescribed ...... in combination study in rats.
@en
Impact of currently prescribed ...... in combination study in rats.
@nl
type
label
Impact of currently prescribed ...... in combination study in rats.
@en
Impact of currently prescribed ...... in combination study in rats.
@nl
prefLabel
Impact of currently prescribed ...... in combination study in rats.
@en
Impact of currently prescribed ...... in combination study in rats.
@nl
P2093
P2860
P356
P1476
Impact of currently prescribed ...... in combination study in rats.
@en
P2093
P2860
P2888
P356
10.1186/1476-511X-13-35
P577
2014-02-18T00:00:00Z